Rocket Pharmaceuticals (Nasdaq:RCKT) is a late-stage clinical biotech focusing on developing gene therapies for rare pediatric diseases with high unmet need. In 2016, that focus drew in Kinnari Patel, president and COO, and Jonathan Schwartz, chief medical officer of the company. “My passion has been making rare disease drug development more efficient and having more therapies…